This inventor holds 2 USPTO granted patents. Top assignee: Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Hongzhu Bian
Introduction
Hongzhu Bian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 2 patents to his name, Bian's work is recognized for its potential impact on medical therapies.
Latest Patents
Bian's latest patents include the "Imidazotriazine thiobenzamide derivative, and preparation method and application thereof." This patent provides a novel imidazotriazine thiobenzamide derivative, along with a preparation method and its application in drug development for cancer treatment. Another significant patent is the "Thioamide derivative and preparation method and application thereof." This patent describes a thioamide derivative that exhibits high antitumor activity, making it a promising candidate for cancer therapy, either alone or in combination with other drugs.
Career Highlights
Hongzhu Bian is currently employed at Yunbaiyao Zhengwu Science and Technology (Shanghai) Co., Ltd. His work at this company focuses on innovative research and development in the pharmaceutical sector. Bian's contributions are vital in advancing therapeutic options for cancer patients.
Collaborations
Bian collaborates with notable colleagues, including Zhengwu Shen and Bin Deng. Their teamwork enhances the research and development efforts within their organization, fostering an environment of innovation.
Conclusion
Hongzhu Bian's inventive work in the pharmaceutical field, particularly in cancer treatment, showcases his dedication to improving medical therapies. His patents reflect a commitment to innovation that has the potential to benefit many patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile